FGen AG

The ETH-​spinoff FGen, a company specialised in the ultra-​high-throughput analysis of cellular libraries, was acquired by Ginkgo Bioworks, a Boston-​based platform for cell programming. Co-​founded in 2011 by scientists from Sven Panke’s Bioprocess Lab, FGen designs and optimises biotechnological production strains for sustainable bio-​based products. The acquisition represents another major step in D-​BSSE’s goal of advancing bio-​engineering technologies in life sciences worldwide.